- FKNE symposium in ITE 19/9
FENS-Kavli Network of Excellence (FKNE) Symposium, which will take place on 19th September 2025 at “G. Lianis” Amphitheater, Foundation for Research and Technology – Hellas/Crete .
The symposium will bring together researchers from across the field to discuss NEUROSCIENCE THROUGH THE LENS OF DIVERSITY: LEVELS, METHODS, AND MODELS.
- ΠΡΟΣΚΛΗΣΗ ΕΚΔΗΛΩΣΗΣ ΕΝΔΙΑΦΕΡΟΝΤΟΣ ΓΙΑ ΕΡΕΥΝΗΤΙΚΕΣ ΘΕΣΕΙΣ ΣΤΟ ΕΙΠ
HELLENIC PASTEUR INSTITUTE
https://www.pasteur.gr/en/
CALL FOR EXPRESSION OF INTEREST FOR EARLY-STAGE RESEARCHERS
The Hellenic Pasteur Institute (HPI) invites expressions of interest for Researchers in the fields of Microbiology, Immunology and Neurobiology. We are seeking highly motivated and skilled early-stage researchers to join our Institute in the fields of:
a) Parasitology. Interested scientists should have a solid background in the study of intracellular parasites and parasitic diseases and should demonstrate the ability to conduct independent research and possess expertise in areas related to parasites of major public health importance. This includes, but is not limited to, parasite biology, mechanisms of intracellular survival, molecular epidemiology, host-parasite interactions and signaling, parasite immunology, as well as translational applications such as diagnostics, drug development, treatment strategies, and vaccine development. Experience in high-throughput technologies and omics-based approaches (e.g., genomics, transcriptomics, proteomics, or metabolomics) would be desired.
b) Molecular Virology. Interested scientists should have proven ability to conduct research in advancing the molecular understanding of human viruses and have a strong background in focus areas, such as human viral pathogenesis, mechanisms of virus-host interactions, viral translation and replication, viral spread mechanisms, cellular and immunometabolic signaling, antiviral treatments, as well as, translational applications. Additional expertise in (but not limited to): in silico bioinformatics analysis, advanced cell co – culture models, transcriptomics, and nanoparticle tracking analysis will be an important advantage.
c) Immunology. Interested scientists should have a strong scientific background and research interests in the area of homeostasis and tolerance, which encompasses any of the following: inflammation, autoimmune disease, cellular and molecular tolerance mechanisms, immune checkpoints and inhibitors, immunotherapy, regulatory T cells, immune-CNS interactions, enteric immunity, effects of viruses on immune cell responses and natural mechanisms used by immune privileged sites such as brain and testes. Experience with state-of-the-art technologies, including (but not limited to): gene editing in animals and human cells (e.g., CRISPR/Cas9, temporal and spatial gene targeting), genetic engineering/biotechnology, monoclonal antibody and autoantibody production, flow cytometry, advanced bioimaging, animal models of human immune-mediated diseases, high throughput bioinformatics and omics-based approaches and/or single cell and spatial transcriptomics, would be desired.
d) Neurobiology. Interested scientists should have a strong scientific background and research interests in areas such as: brain development and plasticity, brain-environment interactions
and/or inter-organ communication, brain metabolism and its role in health and disease and/or neurodegenerative, neurological, autoimmune neurological disorders. Experience with state-of the-art technologies, including (but not limited to): gene editing (e.g., CRISPR/Cas9), in vivo and functional imaging, electrophysiology (single-cell and whole-cell patch-clamp) and calcium imaging, brain organoid and iPSC-based models, transgenic animal models of neurological diseases and/or high throughput and spatial omics-based approaches is highly desirable.Interested scientists are invited to send a motivation letter accompanied by a short CV (both in English) to prosopiko@pasteur.gr by September 10th, 2025. This call for expression of interest does not constitute an announcement for researcher positions. HPI reserves the right to modify, postpone or cancel the procedure, without prior notice and without any obligation towards the interested scientists who have expressed their interest.
More information can be found at https://www.pasteur.gr/el/theseis-ergasias/call-expression-interest-early-stage-researchers
- CALL FOR ABSTRACTS & REGISTRATION ** 8th Hellenic & Paris Pasteur Institute Young Scientists Joint Conference 2025 **
HELLENIC PASTEUR INSTITUTE
https://www.pasteur.gr/en/
CALL FOR EXPRESSION OF INTEREST FOR EARLY-STAGE RESEARCHERS
The Hellenic Pasteur Institute (HPI) invites expressions of interest for Researchers in the fields of Microbiology, Immunology and Neurobiology. We are seeking highly motivated and skilled early-stage researchers to join our Institute in the fields of:
a) Parasitology. Interested scientists should have a solid background in the study of intracellular parasites and parasitic diseases and should demonstrate the ability to conduct independent research and possess expertise in areas related to parasites of major public health importance. This includes, but is not limited to, parasite biology, mechanisms of intracellular survival, molecular epidemiology, host-parasite interactions and signaling, parasite immunology, as well as translational applications such as diagnostics, drug development, treatment strategies, and vaccine development. Experience in high-throughput technologies and omics-based approaches (e.g., genomics, transcriptomics, proteomics, or metabolomics) would be desired.
b) Molecular Virology. Interested scientists should have proven ability to conduct research in advancing the molecular understanding of human viruses and have a strong background in focus areas, such as human viral pathogenesis, mechanisms of virus-host interactions, viral translation and replication, viral spread mechanisms, cellular and immunometabolic signaling, antiviral treatments, as well as, translational applications. Additional expertise in (but not limited to): in silico bioinformatics analysis, advanced cell co – culture models, transcriptomics, and nanoparticle tracking analysis will be an important advantage.
c) Immunology. Interested scientists should have a strong scientific background and research interests in the area of homeostasis and tolerance, which encompasses any of the following: inflammation, autoimmune disease, cellular and molecular tolerance mechanisms, immune checkpoints and inhibitors, immunotherapy, regulatory T cells, immune-CNS interactions, enteric immunity, effects of viruses on immune cell responses and natural mechanisms used by immune privileged sites such as brain and testes. Experience with state-of-the-art technologies, including (but not limited to): gene editing in animals and human cells (e.g., CRISPR/Cas9, temporal and spatial gene targeting), genetic engineering/biotechnology, monoclonal antibody and autoantibody production, flow cytometry, advanced bioimaging, animal models of human immune-mediated diseases, high throughput bioinformatics and omics-based approaches and/or single cell and spatial transcriptomics, would be desired.
d) Neurobiology. Interested scientists should have a strong scientific background and research interests in areas such as: brain development and plasticity, brain-environment interactions
and/or inter-organ communication, brain metabolism and its role in health and disease and/or neurodegenerative, neurological, autoimmune neurological disorders. Experience with state-of the-art technologies, including (but not limited to): gene editing (e.g., CRISPR/Cas9), in vivo and functional imaging, electrophysiology (single-cell and whole-cell patch-clamp) and calcium imaging, brain organoid and iPSC-based models, transgenic animal models of neurological diseases and/or high throughput and spatial omics-based approaches is highly desirable.Interested scientists are invited to send a motivation letter accompanied by a short CV (both in English) to prosopiko@pasteur.gr by September 10th, 2025. This call for expression of interest does not constitute an announcement for researcher positions. HPI reserves the right to modify, postpone or cancel the procedure, without prior notice and without any obligation towards the interested scientists who have expressed their interest.
- You can still register for the Brain Conference in Crete! Extended deadline: 18 July 2025
Extended deadline: 18 July 2025
Event dates: 27-30 October 2025
This October, the Brain Conference will head to Crete, Greece for the first time ever! Join an interdisciplinary group of outstanding researchers as they dive into this edition’s theme: “Principles of the Adaptive Mind.”
Early bird rates are available until
18 July – learn more and register here.
- Call for 2 postdoc positions in European grant “SPARC-AD”
Title of the project: Integrating multimodal, multiscale imaging and artificial intelligence for early amyloid
detection in their native environment
2x Postdoctoral researchers (up to 7 years after PhD degree)
Duration: 3 years (36 months) each position
Salary: 2692 €/month (equivalent paid in Polish zloty, PLN)
Project partners : Sweden, Canada, Germany, Becker, Poland,
Contact info: Prof Aleksandra Szczepankiewicz, Head of Experimental Medicine Centre, Poznan University of Medical
Summary of the project
Our current understanding on molecular mechanisms that determine early Alzheimer’s disease (AD) progression is very limited. Amyloids start to build up decades before the onset of the first disease symptoms. Thus, there is a need for their early detection. We propose an interdisciplinary project that aims to characterize molecular structures directly in their native environments. Using our multimodal molecular imaging approach, we will identify pathological types of amyloids and resolve their structures. The main methodological breakthrough is the implementation of artificial intelligence (AI) as a powerful tool for mining complex spectroscopic data and uncovering spatiotemporal patterns that may detect early (subtle) structural changes. The anticipated results on amyloid structures resolved directly in cells and tissues will be used for the development of new tracers for early diagnostic and effective anti-amyloid interventions. The consortium’s specific goals are as follows: i) By combining multimodal structural imaging with AI, we aim to develop a comprehensive framework for deep molecular profiling of heterogenic samples like brain tissue; ii) Investigate the relationship between amyloid structure and toxicity using a modeling approach; iii) Explore the formation of amyloid in living systems. Experimental work will involve not only APP mice but also human AD organoids, adding a substantial translational aspect to our research. The strong complementarity within the consortium allows for the design of streamlined multidimensional work packages, ensuring swift progression with mutual contributions from consortium members at each project step. Importantly, our consortium is highly inclusive, gender-equal, and transnational, promoting strong European integration, data, and skill transfer. Collaboration among consortium members via joint supervision of PhD students will be essential at every project stage, with significant mobility of young researchers expected to be a key feature.
Keywords: Early amyloid detection; Molecular profiling; Multimodal analysis; Artificial intelligence; Deep learning